Maggie Wilcox

3.0k total citations
9 papers, 512 citations indexed

About

Maggie Wilcox is a scholar working on Cancer Research, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Maggie Wilcox has authored 9 papers receiving a total of 512 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Oncology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Maggie Wilcox's work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (2 papers) and Ethics in Clinical Research (2 papers). Maggie Wilcox is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (2 papers) and Ethics in Clinical Research (2 papers). Maggie Wilcox collaborates with scholars based in United Kingdom and United States. Maggie Wilcox's co-authors include Nancy E. Davidson, Beverly Moy, Michael Danso, Ian E. Smith, Lisa A. Carey, Gabriel N. Hortobágyi, Douglas Yee, Ann H. Partridge, Steven E. Come and R. Bryan Rumble and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and The Lancet Oncology.

In The Last Decade

Maggie Wilcox

9 papers receiving 499 citations

Peers

Maggie Wilcox

ONCOL

PRM

PFM

Amy Krie United States

Shunji Kamigaki Japan

Angela Sciandivasci Italy

Monica Milano Italy

Khémaies Slimane France

Fatemeh Lorenz-Salehi Germany

Pam K. Mangat United States

Joan B. Heijns Netherlands

Carmen Calfa United States

Nancy G. Iskander United States

Amy Krie United States

Maggie Wilcox

257 ×0.8

ONCOL

268 ×0.9

172 ×1.0

PRM

80 ×1.0

PFM

172 ×2.6

Citations per year, relative to Maggie Wilcox Maggie Wilcox (= 1×) peers Amy Krie

Countries citing papers authored by Maggie Wilcox

Since Specialization

Citations

This map shows the geographic impact of Maggie Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maggie Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maggie Wilcox more than expected).

Fields of papers citing papers by Maggie Wilcox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maggie Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maggie Wilcox. The network helps show where Maggie Wilcox may publish in the future.

Co-authorship network of co-authors of Maggie Wilcox

This figure shows the co-authorship network connecting the top 25 collaborators of Maggie Wilcox. A scholar is included among the top collaborators of Maggie Wilcox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maggie Wilcox. Maggie Wilcox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Smith, Ian, J.F.R. Robertson, Lucy Kilburn, et al.. (2020). Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. The Lancet Oncology. 21(11). 1443–1454. 147 indexed citations

Maxwell, Anthony, Karen Clements, Bridget Hilton, et al.. (2018). Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ. European Journal of Surgical Oncology. 44(4). 429–435. 66 indexed citations

Bhattacharya, Indrani, Laura Moretti, Joanne Haviland, et al.. (2018). Patient advocate involvement in the design and conduct of breast cancer clinical trials requiring the collection of multiple biopsies. Research Involvement and Engagement. 4(1). 22–22. 5 indexed citations

Dowsett, Mitch, Judith M. Bliss, James P. Morden, et al.. (2018). Abstract GS1-03: Peri-operative aromatase inhibitor treatment in determining or predicting longterm outcome in early breast cancer – The POETIC* Trial (CRUK/07/015). Cancer Research. 78(4_Supplement). GS1–3. 15 indexed citations

Singh, Jagdeep, et al.. (2016). Why are mastectomies being performed in breast cancer patients in 2015? The National Mastectomy Decisions Audit (MasDA) – A trainee-led collaborative project. European Journal of Surgical Oncology. 42(5). S51–S52. 1 indexed citations

Wilcox, Maggie, et al.. (2015). The Importance of Quality Patient Advocacy to Biobanks: A Lay Perspective from Independent Cancer Patients Voice (ICPV), Based in the United Kingdom. Advances in experimental medicine and biology. 864. 171–183. 5 indexed citations

Partridge, Ann H., R. Bryan Rumble, Lisa A. Carey, et al.. (2014). Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology. 32(29). 3307–3329. 194 indexed citations

Wilcox, Maggie, Nickalus R. Khan, Joseph H. McAbee, Frederick A. Boop, & Paul Klimo. (2013). Highly cited publications in pediatric neurosurgery. Child s Nervous System. 29(12). 2201–2213. 26 indexed citations

Dowsett, Mitch, I. E. Smith, John Robertson, et al.. (2011). Endocrine Therapy, New Biologicals, and New Study Designs for Presurgical Studies in Breast Cancer. JNCI Monographs. 2011(43). 120–123. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact